Prognostic value of DNA alterations on chromosome 17p13.2 for intrahepatic cholangiocarcinoma.

AIM To characterize and evaluate DNA alterations among intrahepatic cholangiocarcinoma (ICC) patients. METHODS DNA from tumor and corresponding normal tissues of 52 patients was amplified with 33 arbitrary primers. The DNA fragment that alters most frequently in ICC was cloned, sequenced, and identified by comparison with known nucleotide sequences in the genome database (www.ncbi.nlm.nih.gov). The DNA copy numbers of the allelic alterations in cholangiocarcinoma were determined by quantitative real-time PCR and interpreted as allelic loss or DNA amplification by comparison with the reference gene. Associations between allelic imbalance and clinicopathological parameters of ICC patients were evaluated by chi2-test. The Kaplan-Meier method was used to analyze survival rates. RESULTS From 33 primers, an altered DNA fragment (518 bp) amplified from BC17 random primer was found frequently in the tumors analyzed and mapped to chromosome 17p13.2. Sixteen of 52 (31%) cases showed DNA amplification, while 7 (13%) showed allelic loss. Interestingly, DNA amplification on chromosome 17p13.2 was associated with a good prognosis, median survival time (wk) of amp vs no amp was 44.14 vs 24.14, P = 0.002; whereas allelic loss of this DNA sequence corresponded with a poor prognosis, median survival time (wk) of loss vs no loss was 18.00 vs 28.71, P = 0.019). Moreover, Kaplan-Meier curves comparing the DNA alterations with survival depicted highly significant separation that the median survival time equal to DNA amplification, allelic loss, and normal was 44.14 wk, 18.00 wk, and 24.29 wk, respectively (P = 0.005). CONCLUSION Alterations in the DNA sequence on chromosome 17p13.2 may be involved in cholangio-carcinogenesis, and could be used as a prognostic marker in the treatment of ICC patients.

[1]  Shirley A. Miller,et al.  A simple salting out procedure for extracting DNA from human nucleated cells. , 1988, Nucleic acids research.

[2]  K. Livak,et al.  DNA polymorphisms amplified by arbitrary primers are useful as genetic markers. , 1990, Nucleic acids research.

[3]  J. Welsh,et al.  Fingerprinting genomes using PCR with arbitrary primers. , 1990, Nucleic acids research.

[4]  H. Bartsch,et al.  opisthorchis viverrini infestation and endogenous nitrosamines as risk factors for cholangiocarcinoma in thailand , 1991, International journal of cancer.

[5]  M. Haswell-Elkins,et al.  Opisthorchis viverrini infection in Northeast Thailand and its relationship to cholangiocarcinoma , 1992, Journal of gastroenterology and hepatology.

[6]  D. Parkin,et al.  Cholangiocarcinoma: epidemiology, mechanisms of carcinogenesis and prevention. , 1993, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[7]  P. Watanapa.  Cholangiocarcinoma in patients with opisthorchiasis , 1996, The British journal of surgery.

[8]  S. Pinlaor,et al.  K-ras oncogene and p53 gene mutations in cholangiocarcinoma from Thai patients. , 1998, The Southeast Asian journal of tropical medicine and public health.

[9]  J. Jorcano,et al.  The use of arbitrarily primed polymerase chain reaction in cancer research , 1999, Electrophoresis.

[10]  Y. Nakanuma,et al.  In situ nucleic acid detection of human telomerase in intrahepatic cholangiocarcinoma and its preneoplastic lesion , 1999, Hepatology.

[11]  Y. Matsuura,et al.  Long-term survival of peripheral intrahepatic cholangiocarcinoma with metastasis to the para-aortic lymph nodes. , 2000, Surgery.

[12]  Y. Nakanuma,et al.  Precancerous lesions of intrahepatic cholangiocarcinoma. , 2000, Journal of hepato-biliary-pancreatic surgery.

[13]  S. Kawasaki,et al.  Long-term survival and prognostic factors in the surgical treatment of mass-forming type cholangiocarcinoma. , 2000, Surgery.

[14]  W. Kim,et al.  Allelotype Analysis of Intrahepatic Cholangiocarcinoma , 2000, Modern Pathology.

[15]  H. Kinoshita,et al.  Clinicopathological factors predicting outcome after resection of mass‐forming intrahepatic cholangiocarcinoma , 2001, The British journal of surgery.

[16]  M. Shimada,et al.  Value of lymph node dissection during resection of intrahepatic cholangiocarcinoma , 2001, The British journal of surgery.

[17]  T. Patel.  Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States , 2001, Hepatology.

[18]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[19]  T. Limpaiboon,et al.  Microsatellite alterations in liver fluke related cholangiocarcinoma are associated with poor prognosis. , 2002, Cancer letters.

[20]  Naoki Matsumura,et al.  A long-term survivor of intrahepatic cholangiocarcinoma with lymph node metastasis: a case report. , 2002, Japanese journal of clinical oncology.

[21]  H. Thomas,et al.  Changing international trends in mortality rates for liver, biliary and pancreatic tumours. , 2002, Journal of hepatology.

[22]  P. Watanapa,et al.  Liver fluke‐associated cholangiocarcinoma , 2002, The British journal of surgery.

[23]  K. Endo,et al.  ERBB‐2 overexpression and cyclooxygenase‐2 up‐regulation in human cholangiocarcinoma and risk conditions , 2002, Hepatology.

[24]  G. Gores.  Cholangiocarcinoma: Current concepts and insights , 2003, Hepatology.

[25]  Kyucheol Cho,et al.  Hypermethylation of XIAP-associated factor 1, a putative tumor suppressor gene from the 17p13.2 locus, in human gastric adenocarcinomas. , 2003, Cancer research.

[26]  Y. Maehara,et al.  Human WISP1v, a member of the CCN family, is associated with invasive cholangiocarcinoma , 2003, Hepatology.

[27]  M. Miwa,et al.  Infrequent microsatellite instability in liver fluke infection‐associated intrahepatic cholangiocarcinomas from Thailand , 2003, International journal of cancer.

[28]  Motoko Sasaki,et al.  Anatomic and molecular pathology of intrahepatic cholangiocarcinoma. , 2003, Journal of hepato-biliary-pancreatic surgery.

[29]  K. McGlynn,et al.  Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase? , 2004, Journal of hepatology.

[30]  I. Screpanti,et al.  Chromosome 17p Deletion in Human Medulloblastoma: A Missing Checkpoint in the Hedgehog Pathway , 2004, Cell cycle.

[31]  J. Wands,et al.  The molecular pathogenesis of cholangiocarcinoma. , 2004, Seminars in liver disease (Print).

[32]  Laurent Bodin,et al.  Determination of Cytochrome P450 2D6 (CYP2D6) Gene Copy Number by Real-Time Quantitative PCR , 2005, Journal of biomedicine & biotechnology.

[33]  R. Aubin,et al.  Accurate Determination of Zygosity in Transgenic Rice by Real-time PCR Does Not Require Standard Curves or Efficiency Correction , 2006, Transgenic Research.

[34]  H. Tagawa,et al.  Genome‐wide array‐based comparative genomic hybridization of natural killer cell lymphoma/leukemia: Different genomic alteration patterns of aggressive NK‐cell leukemia and extranodal Nk/T‐cell lymphoma, nasal type , 2005, Genes, chromosomes & cancer.

[35]  S. Wongkham,et al.  Novel DNA amplification on chromosomes 2p25.3 and 7q11.23 in cholangiocarcinoma identified by arbitrarily primed polymerase chain reaction , 2005, Journal of Cancer Research and Clinical Oncology.

[36]  N. Nowak,et al.  Array comparative genomic hybridisation (aCGH) analysis of premenopausal breast cancers from a nuclear fallout area and matched cases from Western New York , 2005, British Journal of Cancer.

[37]  D. Amadori,et al.  Loss of heterozygosity at 17p13.3-ter, distal to TP53, correlates with negative hormonal phenotype in sporadic breast cancer. , 2005, Oncology reports.

[38]  S T Holgate,et al.  Gene expression in peripheral blood mononuclear cells from patients with chronic fatigue syndrome , 2005, Journal of Clinical Pathology.

[39]  K. P. Singh,et al.  SKCG-1: a new candidate growth regulatory gene at chromosome 11q23.2 in human sporadic Wilms tumours , 2006, British Journal of Cancer.

[40]  T. Eisen,et al.  Variants in the GH-IGF axis confer susceptibility to lung cancer. , 2006, Genome research.

[41]  S. Kubo,et al.  A long-term survivor of intrahepatic cholangiocarcinoma with paraaortic lymph node metastasis , 2006, Journal of Gastroenterology.

[42]  T. Schmid,et al.  High rate of molecular alteration in histologically tumour-free bronchial epithelium of NSCLC patients detected by multicolour fluorescence in situ hybridisation. , 2006, Oncology reports.